We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • September 2014
  • 70 pages

EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023 Summary Breast cancer is a malignant tumor that originates in the breast tissues. Most breast cancers are invasive tumors that have grown beyond the ducts or lobules of the breast and can metastasize to other parts of the body ...

Industries: Pathology | Countries: Japan, World

Polycystic Kidney Disease - Pipeline Review, H2 2014

Polycystic Kidney Disease - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 93 pages

Polycystic Kidney Disease - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Polycystic Kidney Disease - Pipeline Review, H2 2014', provides an overview of the Polycystic Kidney Disease's therapeutic pipeline. This report provides comprehensive information on the therapeutic development fo ...

Industries: Pathology | Countries: World, Japan

Renal Anemia - Pipeline Review, H2 2014

Renal Anemia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 117 pages

Renal Anemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Renal Anemia - Pipeline Review, H2 2014', provides an overview of the Renal Anemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Renal Anemia, complete with comparative ...

Industries: Pathology | Countries: Japan, World, United States

Allergic Conjunctivitis - Pipeline Review, H2 2014

Allergic Conjunctivitis - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 66 pages

Allergic Conjunctivitis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Allergic Conjunctivitis - Pipeline Review, H2 2014', provides an overview of the Allergic Conjunctivitis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Allergic ...

Industries: Pathology | Countries: World, United States, Japan

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • August 2014
  • 43 pages

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. ...

Industries: Pathology | Countries: Japan, China, World, United States, Spain, Italy, France, Germany

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

Teijin Pharma Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States, Spain, South Korea, Japan, China

Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States

Sildenafil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sildenafil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Sitagliptin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Sitagliptin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • August 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.